Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • After defying consumer rights, Booktopia invests $12 million in a dedicated customer fulfilment centre
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • After defying consumer rights, Booktopia invests $12 million in a dedicated customer fulfilment centre
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • After defying consumer rights, Booktopia invests $12 million in a dedicated customer fulfilment centre
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • After defying consumer rights, Booktopia invests $12 million in a dedicated customer fulfilment centre
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • After defying consumer rights, Booktopia invests $12 million in a dedicated customer fulfilment centre
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Shareholders left empty-handed with Booktopia sold by administrators for no return
    Shareholders left empty-handed with Booktopia sold by administrators for no return
    • News

  • Booktopia requests ASX suspension extension amid funding concerns, ACCC fine still not paid off
    Booktopia requests ASX suspension extension amid funding concerns, ACCC fine still not paid off
    • News

  • Booktopia to layoff 50 staff in restructure that will reinstate Founder Tony Nash to Executive team
    Booktopia to layoff 50 staff in restructure that will reinstate Founder Tony Nash to Executive team
    • News

  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

  • Booktopia sales plummet as Australians say no to books as Christmas presents
    Booktopia sales plummet as Australians say no to books as Christmas presents
    • News

  • Did National Tyre & Wheel pull a swifty with this acquisition?
    • News

    Did National Tyre & Wheel pull a swifty with this acquisition?

    The rise of electronic vehicles may be altering the dynamics of how a car is made in the future but one constant will remain – they’ll need tyres, a business that National Tyre & Wheel (ASX: NTD) is cashing in on despite being one of the more boring companies listed on the bourse. Lodging their

    Read More
    Public
  • PharmAust shrinks proprietary tablet for use in COVID-19 trials
    • News

    PharmAust shrinks proprietary tablet for use in COVID-19 trials

    Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets.  The clinical stage biotechnology company has manufactured smaller versions of their lead asset, MPL, a potent small molecule drug that has been shown to affect key pathways associated with cancer and other diseases. PharmAust have studied MPL for

    Read More
    Public
  • Micro Investing app gets not-so-micro with $10m investment from Seven West Media
    • News

    Micro Investing app gets not-so-micro with $10m investment from Seven West Media

    Everyone’s favourite micro investing app is growing!  After their recent milestone of $1 billion in Funds Under Management, Raiz (ASX: RZI) is using that momentum to drive further growth, today announcing that a strategic investment has been made in the Company by Seven West Media (ASX: SWM). Australia’s largest diversified media business, Seven West Media

    Read More
    Public
  • Burner phones be gone as Flexiroam partners with Second Phone Number eSim app
    • News

    Burner phones be gone as Flexiroam partners with Second Phone Number eSim app

    Gone are the days of using two separate phones for whatever reason we won’t speculate on. Instead with the emergence of eSims, individual phones have the ability to connect via separate phone numbers – a trend being capitalised on communications company Flexiroam (ASX: FXR) which has entered into a reseller agreement with BP Mobile. Under

    Read More
    Public
  • Better than a sudoku: could this drug be the key to preventing Alzheimer’s?
    • News

    Better than a sudoku: could this drug be the key to preventing Alzheimer’s?

    Our minds can be our greatest asset and our biggest enemy. The same humans that built aeroplanes, rockets and the internet are just as prone to ailments like depression, anxiety and functional cognitive decline. Unfortunately when it comes to cognition, doing the odd sudoku probably won’t cut it if you’re hoping to maintain your current

    Read More
    Public
  • Xref engages AI to assess your social media presence alongside job application
    • News

    Xref engages AI to assess your social media presence alongside job application

    Prospective employees have long been told to change their profile pictures to something more ‘professional’ when applying for a job but even with those tweaks, HR tech company Xref (ASX: XF1) may still find that embarrassing pic of you shotgunning UDLs in your underwear to the cheers of many.  Social media and Google searches have

    Read More
    Public
  • Aussie opioid manufacturer cashed up following $33m sale of facility
    • News

    Aussie opioid manufacturer cashed up following $33m sale of facility

    While prescription opioids have been getting a pretty bad rap over the past few years amid revelations in the US about a certain Sackler family, they still have a vital role to play in healthcare where good guys like Palla Pharma (ASX: PAL) have strengthened their balance sheet with the sale of their manufacturing facility

    Read More
    Public
  • National expansion continues as Apiam acquire 4 new vet clinics amid revenue surge
    • News

    National expansion continues as Apiam acquire 4 new vet clinics amid revenue surge

    With business booming in response to a 20% increase in pet ownership amongst Australians during the pandemic, veterinary operator Apiam Animal Health (ASX: AHX) has continued its acquisition spree by adding 4 new clinics to their national network. The clinics include 3 in Queensland located within the Fraser Coast region and one located in Armidale,

    Read More
    Public
  • Laying down new roots: Roots ag-tech expands into Africa
    • News

    Laying down new roots: Roots ag-tech expands into Africa

    Anyone who has tried to grow coriander on their apartment balcony (like me) will understand that food production, even that of a measly herb, is somewhat of an art form. The climate, topography and differences in soil all affect the type and quality of foods that can be grown in certain regions.  Adding to an

    Read More
    Public
  • This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in
    • News

    This small biotech is the definition of a quiet achiever, here’s why it might be time to tune in

    Clinical stage pharmaceutical company Pharmaxis (ASX: PXS) is in a transformation phase as their clinical pipeline progresses towards multiple value inflection points.  With two products already on market, the Company has a great base from which to fund their ongoing clinical product development. Adding to that, the company has just completed a capital raise viaRead More
    Public
  • «
  • ‹
  • 208
  • 209
  • 210
  • 211
  • 212
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.